Inventor
BOCK MARK G
US92 patents
⚠️ This page may combine multiple inventors who share the name “BOCK MARK G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK & CO INC
44 patentsUS4820834AApr 11, 1989
Benzodiazepine analogs
MERCK & CO INC161 citations99
US5464788ANov 7, 1995
Tocolytic oxytocin receptor antagonists
MERCK & CO INC135 citations98
US5324726AJun 28, 1994
Benzodiazepine analogs
MERCK & CO INC137 citations98
US5756504AMay 26, 1998
Tocolytic oxytocin receptor antagonists
MERCK & CO INC112 citations97
US5665719ASep 9, 1997
Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
MERCK & CO INC74 citations96
US5206234AApr 27, 1993
Benzolactam analogs as antagonists of cck
MERCK & CO INC61 citations96
US5004741AApr 2, 1991
Methods of antagonizing CCK or gastrin with benzodiazepine analogs
MERCK & CO INC59 citations96
US4309430AJan 5, 1982
Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same
MERCK & CO INC53 citations96
US5220018AJun 15, 1993
Cholecystokinin antagonists
MERCK & CO INC29 citations93
US5220017AJun 15, 1993
Cholecystokinin antagonists
MERCK & CO INC36 citations93
US5210082AMay 11, 1993
2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
MERCK & CO INC25 citations93
US5185331AFeb 9, 1993
Triazolobenzodiazepines
MERCK & CO INC23 citations93
US5177071AJan 5, 1993
1,4-benzodiazepines with 6-membered heterocyclic rings to treat panic and anxiety disorder
MERCK & CO INC47 citations93
US5175159ADec 29, 1992
3-substituted-1,4-benzodiazepines as oxytocin antagonists
MERCK & CO INC36 citations93
US5166151ANov 24, 1992
2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
MERCK & CO INC41 citations93
US4812442AMar 14, 1989
Tripeptide renin inhibitors
MERCK & CO INC26 citations93
US4755508AJul 5, 1988
Benzodiazepine analogs and use as antogonists of gastrin and cholecystokinin
MERCK & CO INC49 citations93
US4479941AOct 30, 1984
Renin inhibitory peptides having PHE13 delection
MERCK & CO INC33 citations93
US4362724ADec 7, 1982
Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic
MERCK & CO INC40 citations93
US4145551AMar 20, 1979
Pyrazine-2-carbonyloxyguanidines
MERCK & CO INC49 citations93
US6436962B1Aug 20, 2002
Arylhydantoin derivatives and uses thereof
MERCK & CO INC34 citations92
US5834464ANov 10, 1998
Imidazolinobenzodiazepines
MERCK & CO INC29 citations92
US5439906AAug 8, 1995
Antiarrhythmic benzodiazepines
MERCK & CO INC24 citations92
US4636491AJan 13, 1987
Renin inhibitory peptides having improved solubility
MERCK & CO INC26 citations92
US4628084ADec 9, 1986
Process for 3-acylamino benzodiazepines
MERCK & CO INC28 citations92
US6919343B2Jul 19, 2005
N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
MERCK & CO INC14 citations83
US4554272ANov 19, 1985
Substituted quinazolino-1,4-benzodiazepin-6,9-diones and their preparation
MERCK & CO INC20 citations82
US4454132AJun 12, 1984
Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension
MERCK & CO INC22 citations82
US4309540AJan 5, 1982
Substituted pyrazinyl-1,2,4-oxadiazoles
MERCK & CO INC28 citations82
US5620993AApr 15, 1997
Alpha-1a adrenergic receptor antagonists
MERCK & CO INC17 citations80
US6908921B2Jun 21, 2005
Quinoxalinone derivatives as bradykinin B1 antagonists
MERCK & CO INC7 citations74
US6255315B1Jul 3, 2001
Alpha 1a adrenergic receptor antagonists
MERCK & CO INC11 citations74
US6143750ANov 7, 2000
Alpha 1a adrenergic receptor antagonists
MERCK & CO INC8 citations74
US6037354AMar 14, 2000
Alpha 1a adrenergic receptor antagonists
MERCK & CO INC6 citations74
US5378838AJan 3, 1995
Benzodiazepine cholecystokinin antagonists
MERCK & CO INC8 citations74
US5225528AJul 6, 1993
Cyclic hexapeptide oxytocin antagonists
MERCK & CO INC14 citations74
US4847248AJul 11, 1989
1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists
MERCK & CO INC19 citations74
US4724237AFeb 9, 1988
2-substituted-aminomethyl-1,4-benzodiazepines
MERCK & CO INC8 citations74
US4663310AMay 5, 1987
Renin inhibitors containing 2-substituted statine
MERCK & CO INC11 citations74
US4663321AMay 5, 1987
Triazolobenzodiazepines and pharmaceutical use
MERCK & CO INC17 citations74
US4661473AApr 28, 1987
Renin inhibitors containing peptide isosteres
MERCK & CO INC19 citations74
US4559339ADec 17, 1985
Indol-3-yl-quinazolino-1,4-benzodiazepin-5,13-diones
MERCK & CO INC7 citations74
US5218114AJun 8, 1993
Cholecystokinin antagonists
MERCK & CO INC15 citations73
US4487963ADec 11, 1984
Enantioselective synthesis of 4-amino-3-hydroxy-2,4-(disubstituted)pentanoic acid
MERCK & CO INC7 citations73
BEBERNITZ GREGORY RAYMOND
3 patentsMERCK SHARP & DOHME
1 patentBOCK MARK G
1 patentSALK INST FOR BIOLOGICAL STUDI
1 patentShowing the top 50 of 92 patents by PatentIndex Score.